Prospectus Supplement No. 2, dated September 8, 2000, Rule 424(c)
to Prospectus, dated June 30, 2000. File No. 333-33242
ALLIANCE PHARMACEUTICAL CORP.
COMMON STOCK
------------
This prospectus supplement relates to the public offering of shares of
our common stock by the selling shareholders named in the prospectus referenced
above.
The Selling Shareholder Table in the prospectus referenced above is
hereby amended. Portions of the warrant to purchase 760,000 shares of common
stock, dated June 10, 1999, owned by Roth Capital Partners, one of the selling
shareholders, has been transferred. The warrant is now owned as follows:
<TABLE>
<CAPTION>
NUMBER OF SHARES
OF COMMON STOCK NUMBER OF SHARES OF NUMBER OF SHARES OF COMMON
BENEFICIALLY COMMON STOCK TO BE STOCK BENEFICIALLY OWNED ACQUISITION OF COMMON
OWNED BEFORE OFFERED BY THIS AFTER THE OFFERING(2) STOCK OFFERED BY THIS
SELLING SHAREHOLDERS OFFERING(1) PROSPECTUS PROSPECTUS
NUMBER PERCENTAGE
<S> <C> <C> <C> <C> <C>
Roth Capital Partners 639,273 639,273 -0- -0- Represents 639,273 shares
of common stock
underlying a warrant,
dated June 10, 1999,
exercisable at $3.675 per
share.
Jan A. Dekker 332,883 173,333 159,550 * Represents 117,911 shares
of common stock
underlying a warrant,
dated June 10, 1999,
exercisable at $3.675 per
share and 55,422 shares
of common stock
underlying a warrant,
dated July 2, 1999,
exercisable at $2.95 per
share.
Gregory Huston 19,000 2,000 17,000 * Represents 2,000 shares of
common stock underlying a
warrant, dated June 10,
1999, exercisable at
$3.675 per share
Barry Pearl 2,116 816 1,300 * Represents 816 shares of
common stock underlying a
warrant, dated June 10,
1999, exercisable at
$3.675 per share
* Indicates ownership of less than 1% of outstanding shares
(1) Includes the shares of common stock underlying the warrants, 5%
subordinated convertible debentures, 6% subordinated convertible notes and
Series D Preferred Stock being offered by this prospectus.
(2) based on 50,384,120 shares of Alliance's common stock outstanding and which
number assumes the sale of all the shares of common stock registered under
this prospectus to persons who are not affiliates of the selling
shareholders.
</TABLE>